Please turn to Slide 3. We have provided you with a summary of key performance metrics ... and simplifying our organizational structure, which is tracking to the timing we laid out on our last ...

Mick McCloskey; Vice President-Treasury & Investor Relations; 3D Systems Corp. Jeffrey Graves; President, Chief Executive Officer, Director; 3D Systems Corp. Jeffrey Creech; Chief Financial Officer, ...

NICE has recommended that there is not enough evidence comparing drug-eluting stents to determine whether price variation between different stents is justified. NHS trusts should provide access to a ...

which includes technology and organizational improvements that enable us to maintain operational excellence as we become a larger organization. Slide 8 highlights our fortunate position of having ...

The assessment part of the report embraces in-depth Hepatitis B commercial assessment and clinical assessment of the Hepatitis B pipeline products from the pre-clinical developmental phase to the ...

Welcome to the Revolution Medicines Q1 2025 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over ...

Q1 2025 Earnings Call Transcript May 5, 2025 Operator: Good afternoon and welcome to Castle Biosciences First Quarter 2025 ...

Net sales (as reported) of $773 million, increased 0.3% from prior year. Adjusted net sales (excluding the impact of a ...

As shown in the following financial summary slide, these strategic moves are expected to support earnings growth toward the upper end of Unitil’s long-term guidance range: Unitil’s first ...

As shown in the following financial summary slide, these strategic moves are expected to support earnings growth toward the upper end of Unitil’s long-term guidance range: Unitil’s first quarter ...

Travis is somebody that we view has the potential to do that.” Despite the slide, Sanders maintained composure, addressing family and friends in a video: “All this is is of course more fuel to ...